GlassScriptPhysician profile
Howard M Hammer
NPI 1407841539
$7,493.38
in general payments reported to CMS, 2019-2025
29 companies · $277 in 2025
The $277 reported for 2025 was more than what a typical Plastic Surgery Within The Head & Neck provider received nationally (typical 2025 total: $238).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $936 · 2020: $230 · 2021: $588 · 2022: $1,710 · 2023: $610 · 2024: $3,143 · 2025: $277.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,061 · Travel and Lodging: $1,970.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,060.74 |
| Travel and Lodging | $1,969.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $2,592.74 | 2021-2024 | Coblation, Tula, Halo |
| Inspire Medical Systems, INC. | $983.45 | 2019-2025 | Inspire |
| Stryker Corporation | $949.50 | 2019-2025 | Scopis Ent |
| Acclarent, INC | $698.44 | 2019-2024 | Trudi Nav Cable |
| Aerin Medical INC. | $476.68 | 2019-2025 | |
| Optinose US, INC. | $333.33 | 2019-2025 | |
| Glaxosmithkline, LLC. | $270.69 | 2022-2024 | Nucala |
| Regeneron Healthcare Solutions, INC. | $243.70 | 2019-2022 | |
| Genzyme Corporation | $240.81 | 2021-2023 | |
| Intersect Ent, INC. | $156.90 | 2019-2022 | |
| Alk-Abello, INC | $131.10 | 2019-2021 | |
| Cochlear Americas | $79.52 | 2022-2024 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Neurent Medical Limited | $38.63 | 2022 | |
| Fujifilm Healthcare Americas Corporation | $35.43 | 2020 | |
| Kerecis Limited | $28.20 | 2022 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $24.48 | 2019 | |
| Hikma Pharmaceuticals USA | $23.52 | 2023 | Ryaltris |
| Integra Lifesciences Corporation | $20.92 | 2024 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Fujifilm New Development USA, INC. | $20.68 | 2019 | |
| Tactile Systems Technology INC | $18.55 | 2019 | |
| Merz North America, INC. | $17.33 | 2019 | |
| Arbor Pharmaceuticals, INC. | $17.05 | 2019 | |
| Paratek Pharmaceuticals, INC. | $16.96 | 2025 | Xhance |
| Olympus America INC. | $16.33 | 2020 | |
| Phadia US INC. | $15.76 | 2021 | |
| Advanced Respiratory, INC | $12.27 | 2019 | |
| Novartis Pharmaceuticals Corporation | $11.38 | 2019 | |
| Cook Medical LLC | $11.03 | 2019 | |
| Glenmark Therapeutics INC. | $8.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Howard Hammer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.